Impedimed Ltd (OTCPK:IPDQF)
$ 0.048 0 (0%) Market Cap: 70.20 Mil Enterprise Value: 54.36 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 0/100

Q4 2020 ImpediMed Ltd Earnings Call Transcript

Jul 27, 2020 / 11:15PM GMT
Release Date Price: $0.0562
Operator

Thank you for standing by, and welcome to the ImpediMed Quarterly Results Investor Call. (Operator Instructions)

I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Ashley. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 June 2020.

Before I begin, I would like to once more thank the clinicians, staff and frontline workers in the fight against COVID-19. Every day, they courageously face untold challenges to get us through this global pandemic. I also want to take a moment to thank our employees who have tirelessly transformed this company to effectively support our customers during this challenging times as well.

Joining us on the call today is Tim Cruickshank, our Senior Vice President of Finance and acting CFO; and Mike Bassett, our Senior Vice President of Corporate and Strategic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot